Clinical trials: Microvascular Obstruction (MVO)
Microvascular Obstruction
A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention
The purpose of this study is to determine whether intravenous temanogrel is a safe and effective treatment for microvascular obstruction (MVO) in adult participants undergoing percutaneous coronary intervention (PCI).
- Trial name
- NCT04848220
- Testing
- Temanogrel
- Where
- 12 sites in United States, Australia and 3 more
- Volunteers
- 29 people
- Sponsor
- Pfizer
Microvascular Obstruction (MVO), STEMI - ST Elevation Myocardial Infarction
Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II
A prospective, multicenter, international single-arm, pivotal clinical study designed to validate the performance of the CoFI system in detecting MVO in STEMI subjects, as confirmed by CMRI.
- Trial name
- MOCA II (NCT06909578)
- Testing
- CorFlow Controlled Flow Infusion System - CoFI™
- Volunteers
- 200 people
- Sponsor
- CorFlow Therapeutics AG